OPRE Evaluation - National and Tribal Evaluation of the 2nd Generation of the Health Profession Opportunity Grants [descriptive evaluation, impact evaluation, cost-benefit analysis study, pilot study]
ICR 202110-0970-005
OMB: 0970-0462
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0970-0462 can be found here:
OPRE Evaluation - National
and Tribal Evaluation of the 2nd Generation of the Health
Profession Opportunity Grants [descriptive evaluation, impact
evaluation, cost-benefit analysis study, pilot study]
No
material or nonsubstantive change to a currently approved
collection
No
Regular
10/14/2021
Requested
Previously Approved
07/31/2024
07/31/2024
7,298
11,815
2,977
4,525
0
0
Between August 2015 and July 2019, OMB
has approved several information collection instruments, procedures
and supporting materials in support of the HPOG 2.0 National and
Tribal Evaluation. These include baseline data collection from all
study participants, data collection protocols and procedures for
the HPOG 2.0 Tribal Evaluation, and several instruments in support
of the National Evaluation, including Short-Term and Intermediate
Follow-up Surveys to support the HPOG 2.0 National Evaluation
impact study. In July 2021, OMB approved Instrument 12a
COVID-Cohort Short-term Survey (COVID-19 Cohort STS) and supporting
materials. Since approval, the following events have led to the
need for minor changes so some of the currently approved
information collection. • OPRE’s Privacy Analyst reviewed the
advance letter (Attachment K) and requested changes. An updated
Attachment K is included with this request. • While preparing to
program the COVID-19 Cohort STS (Instrument 12a), the team
identified revisions to language that would help with the clarity
of the request. The team also had a change in staffing resulting in
a necessary update to contact information. An updated Instrument
12a is included with this request. • The success of the
Intermediate Follow-up Survey Critical Items Only (Instrument
18a)—which was still underway at the time the COVID-19 Cohort STS
was submitted to OMB for review and approval – led the team to
create a similar Critical Items Instrument for the COVID-19 Cohort
STS. This Critical Items Survey is labeled as Instrument 12b and is
included with this request.
The original burden estimate
for Instrument 12a, the COVID-19 Cohort STS, was based on a
presumed sample size of 7,500 study participants, a 75 percent
response rate (5,625 responses), and a 60-minute length. The
revised burden estimates reflect the same total number of responses
(5,625), however, the overall response rate allows for 518
interviews to be completed using the shorter, critical items
version of the COVID-19 Cohort STS (Instrument 12b). The shorter
interview, the subject of this nonsubstantive change request, is
estimated at just 20 minutes. The requested change reduces the
original burden estimate for COVID-19 Cohort STS from 1,875 hours
annually to 1,851 hours annually, a burden reduction of 6.2 percent
annually. Burden estimates were reduced to 0 for Instrument 1
(PAGES Participant-level baseline data collection, tribal and
non-tribal grantees) and for Instruments 18 and 18a now that the
study enrollment and the Intermediate Follow-up survey data
collection are complete.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.